 ImmuCell Corporation Nasdaq: ICCC the Company or ImmuCell, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced a change in the location of its 2020 Annual Meeting of Stockholders. In light of the COVID-19 pandemic and in an effort to protect the health and safety of the Companys stockholders, employees and communities, the Annual Meeting will be held by remote communication in the form of both a dial-in conference call and an audio webcast rather than an in-person event. Stockholders of record of the Companys common stock at the close of business on Tuesday, April 14, 2020, are invited to participate in the Annual Meeting by dialing 844-855-9502. 